Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
VEGF
>>
Phase 2
1
2
»
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
2
4
6
8
10
12
14
16
18
20
thrombospondin-1 mimetic
(ABT-510) / AbbVie
simtuzumab
(GS 6624) / Gilead
foretinib
(GSK1363089) / Exelixis
BI 836880
/ Boehringer Ingelheim
VEGFR1-1084
/ Tokyo Medical University
BMS690514
/ BMS
ENMD-2076
/ CASI
golvatinib
(E7050) / Eisai
olinvacimab
(TTAC-0001) / PharmAbcine
glesatinib
(MGCD265) / BMS
ningetinib
(CT053PTSA) / HEC Pharm
Angiocept
(pegdinetanib) / BMS
PAN-90806
/ PanOptica
SB-509
/ Biogen
certepetide
(LSTA1) / Lisata Therap
ESK981
/ Esanik Therap
HA121-28
/ CSPC Pharma
ixoberogene soroparvovec
(ADVM-022) / Adverum Biotech
Pravitinib
(carboxyamidotriazole orotate) / Tactical Therap
VXM01
/ Vaximm
axitinib intradermal
(AIV001) / AiViva BioPharma
icrucumab
(IMC-18F1) / Eli Lilly
ilorasertib
(ABT348) / AbbVie
nesvacumab/aflibercept intravitreal
(REGN 910-3) / Regeneron, Bayer
rebastinib
(DCC-2036) / Deciphera
telatinib
(BAY 57- 9352) / EddingPharm
vorolanib
(EYP-1901) / EyePoint Pharma
AEE788
/ Novartis
ANG-3070
/ Elicio Therap
CU06
/ Thea Laboratories
MP0250
/ Molecular Partners
VEGFR2-169
/ U Tokyo
XL820
/ Exelixis
axitinib injectable suspension
(CLS-AX) / Clearside Biomedical
encoberminogene rezmadenovec
(XC001) / XyloCor
gersizangitide
(AXT107) / Asclepix
rinucumab/aflibercept intravitreal
(REGN2176-3) / Regeneron, Bayer
sunitinib maleate
(GB-102) / CalciMedica
tivozanib eye drops
(KHK4951) / Kyowa Kirin
vanucizumab
(RG7221) / Roche
4D-150
/ 4D Molecular Therap
AZD8601
/ Moderna
BTG-002814
/ Boston Scientific
CSL346
/ CSL Behring
D-4517.2 SC
/ Ashvattha Therap
DE-120
/ Santen
HB0025
/ Zhejiang Huahai Pharma
JI-101
/ Jubilant Pharmova
KH631
/ Chengdu Kanghong Pharma
Kominox
(sodium metaarsenite) / Komipharm
1
2
»
